文献速递生殖医学

染色体缺陷与男性因素不育

Chromosome defects and male factor infertility.
PubMed 文献 · Fertil Steril · 2025-04-30

本文为叙述性综述,阐述染色体异常作为男性因素不育病因的技术检测方法与临床后果。核型异常约占不育男性的6%,包括Klinefelter综合征等数目异常及易位、倒位、插入和拷贝数变异等结构异常。作者认为染色体评估标准应超出现有美国泌尿外科学会/美国生殖医学学会指南,后者推荐对非梗阻性无精子症和严重少精子症(<5百万精子/mL)男性行核型分析。

要点

  • 核型异常约占不育男性的6%,是男性因素不育的重要原因。
  • 指南推荐对非梗阻性无精子症和严重少精子症(<5百万精子/mL)男性行核型分析。
  • 染色体异常也可存在于精子浓度低于20百万精子/mL的男性及部分精子正常的不育男性中。

核心结论

  • 核型异常是男性因素不育的重要原因,约占不育男性的6%。
  • 现有指南推荐对非梗阻性无精子症和严重少精子症(<5百万精子/mL)男性行核型分析是可靠的。
  • 作者认为诊断男性因素不育所需的染色体评估标准应超出现有指南范围。

研究设计与样本

  • 叙述性综述,聚焦染色体异常作为男性因素不育病因的技术检测方法与临床后果。

主要发现

  • 核型异常约占不育男性的6%。
  • 数目异常包括Klinefelter综合征及其他性染色体非整倍体,Klinefelter综合征是生殖医学中最易被忽视的诊断之一。
  • 结构异常包括易位、倒位、插入和拷贝数变异,部分导致生精障碍、少精子症、弱精子症甚至精子正常。
  • 其他结构缺陷影响妊娠结局、子代健康或导致出生缺陷。
  • 精子浓度低于20百万精子/mL的男性中细胞遗传学异常患病率也高于不会接受检测的生育男性。

关键数值与推荐

  • 美国泌尿外科学会/美国生殖医学学会实践指南推荐对非梗阻性无精子症和严重少精子症(<5百万精子/mL)男性行核型分析。
  • 精子浓度低于20百万精子/mL的男性细胞遗传学异常患病率高于生育男性。

临床怎么用

  • 了解男性不育病因可能影响夫妇的治疗选择并改善生殖结局。
  • 先进技术识别微缺失和微重复可指导患者管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although a routine semen analysis and an endocrine evaluation (usually of the gonadotropins and androgen levels) are the cornerstone of clinical diagnostic evaluation of the male seeking evaluation and treatment of the couple with infertility, in recent years, the American Urological Association/American Society for Reproductive Medicine Practice Guidelines for Male Infertility stressed the importance of assessing chromosomal anomalies, such as numerical and structural anomalies in men with spermatogenic failure. This narrative review of chromosomal anomalies as a cause of male factor infertility will provide an understanding of the technical approaches to defining the defects, as well as the clinical consequences of these abnormalities for a wider group of men with infertility. Karyotype anomalies are a significant cause of male factor infertility and are present in approximately 6% of men with infertility. These cytogenetic anomalies include numerical defects that underlie conditions such as Klinefelter syndrome, which is among the most overlooked diagnosis in reproductive medicine, and other sex chromosome aneuploidies. Structural chromosomal defects are more varied and complex and include chromosomal translocations, inversions, insertions, and copy number variations, some of which result in spermatogenic failure, oligozoospermia, asthenozoospermia, or even normozoospermia. Other structural defects affect pregnancy outcomes or health of the offspring conceived or cause birth defects. The criteria needed for a chromosomal assessment for the diagnosis male factor infertility should probably be expanded beyond the existing American Urological Association/American Society for Reproductive Medicine Practice Guidelines. Their recommendation that a karyotype be performed for the evaluation of men with nonobstructive azoospermia and men with severe oligozoospermia (<5 million sperm/mL) is solid; however, the prevalence of cytogenetic anomalies in men with sperm counts below 20 million sperm/mL is also increased compared with fertile men who would not be likely to be tested. Karyotypic anomalies are even present in a subset of men with infertility with normozoospermia. A karyotype can also detect structural chromosomal anomalies, such as translocations that impact male reproductive function and the health of the offspring. Advanced technologies to identify microdeletions and microduplications can also guide patient care. Knowledge of the etiology of the male's infertility may impact the couple's treatment options and improve their reproductive outcomes.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Lamb DJ. Chromosome defects and male factor infertility. Fertil Steril. 2025. PMID: 40311997. doi:10.1016/j.fertnstert.2025.04.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。